Hypnosis in Reducing Pain and Other Side Effects in Women Undergoing Surgery for Breast Cancer

Sponsor
City of Hope Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT00748267
Collaborator
National Cancer Institute (NCI) (NIH)
20
1
28
0.7

Study Details

Study Description

Brief Summary

RATIONALE: Hypnosis may be effective in reducing pain and other side effects in women undergoing surgery for breast cancer.

PURPOSE: This clinical trial is studying how well hypnosis works in reducing pain and other side effects in women undergoing surgery for breast cancer.

Condition or Disease Intervention/Treatment Phase
  • Other: questionnaire administration
  • Procedure: hypnotherapy
  • Procedure: therapeutic conventional surgery
N/A

Detailed Description

OBJECTIVES:
  • To test the feasibility of hypnosis as a pre-operative intervention for the reduction of surgical- and anesthesia-related symptoms in women undergoing lumpectomy with sentinel node biopsy, mastectomy, or mastectomy with lymph node dissection for locally recurrent breast cancer.

  • To identify the physical symptoms (i.e., pain, nausea, and vomiting) and psychological symptoms (i.e., anxiety and distress) of patients undergoing hypnosis.

  • To determine the length of stay in the Post Anesthesia Care Unit of patients undergoing adjunct hypnosis.

  • To describe patient satisfaction with the hypnosis experience.

  • To determine the effect size and calculate the sample needed for a randomized clinical trial using the results of this study.

OUTLINE: Patients undergo a scripted hypnotic intervention over 15 minutes within 1 hour prior to their planned surgical procedure. Upon completion of the intervention, patients proceed to the Preoperative Holding Area of the Surgery and Post Anesthesia Care Unit where they receive the standard of care for lumpectomy with sentinel node biopsy, mastectomy, or mastectomy with lymph node dissection.

Patients undergo collection of demographic information (i.e., age; gender; ethnicity; marital/partnered status; spiritual practice; family members in the home; stress management history; experience with the continuum of imagery/hypnosis practices; perceptions of concentration abilities; and favorite aromas, colors, and scenes from nature) at the time of consent using the Demographic Survey Questionnaire. They also undergo assessment of physical and psychological symptoms (i.e., pain, nausea, vomiting, anxiety, and generalized distress) at baseline (immediately prior to hypnotic induction) and after the intervention (prior to discharge from the Post Anesthesia Care Unit).

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Use of Pre-Operative Hypnosis to Reduce Post-Operative Pain and Anesthesia Related Side-Effects
Study Start Date :
Aug 1, 2008
Actual Primary Completion Date :
Feb 1, 2010
Actual Study Completion Date :
Dec 1, 2010

Outcome Measures

Primary Outcome Measures

  1. Pain as measured by the Condensed Memorial Symptom Assessment Scale (CMSAS)-Modified at baseline (pre-intervention) and prior to discharge from the Post Anesthesia Care Unit []

  2. Nausea as measured by the CMSAS-Modified at baseline and prior to discharge from the Post Anesthesia Care Unit []

  3. Vomiting as measured by the CMSAS-Modified at baseline and prior to discharge from the Post Anesthesia Care Unit []

  4. Generalized distress as measured by the CMSAS-Modified at baseline and prior to discharge from the Post Anesthesia Care Unit []

  5. Anxiety as measured by the CMSAS-Modified at baseline and prior to discharge from the Post Anesthesia Care Unit []

  6. Surgical and anesthesia time []

  7. Recovery time []

  8. Medications []

  9. Levels of consciousness []

  10. Standard clinical measures of levels of anesthesia []

  11. Significant surgical events []

  12. Patient satisfaction []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
DISEASE CHARACTERISTICS:
  • Diagnosis of breast cancer

  • Scheduled for breast surgery (i.e., lumpectomy with sentinel node biopsy, mastectomy, or mastectomy with lymph node dissection) with Dr. Garbaroglio

  • Hormone receptor status not specified

PATIENT CHARACTERISTICS:
  • Menopausal status not specified

  • Able to speak and read English

  • Able to follow instruction

  • No uncontrolled major comorbid mental conditions (i.e., thought disorders)

  • No uncontrolled major physical conditions (i.e., untreated congestive heart failure)

PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics

  • No concurrent reconstruction surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 City of Hope Comprehensive Cancer Center Duarte California United States 91010-3000

Sponsors and Collaborators

  • City of Hope Medical Center
  • National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Michael Lew, MD, City of Hope Comprehensive Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00748267
Other Study ID Numbers:
  • 08029
  • P30CA033572
  • CHNMC-08029
  • CDR0000612523
First Posted:
Sep 8, 2008
Last Update Posted:
Mar 7, 2011
Last Verified:
Mar 1, 2011
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 7, 2011